Group One Trading, L.P. Travere Therapeutics, Inc. Transaction History
Group One Trading, L.P.
- $3.01 Billion
- Q2 2024
A detailed history of Group One Trading, L.P. transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 36,764 shares of TVTX stock, worth $527,563. This represents 0.01% of its overall portfolio holdings.
Number of Shares
36,764
Previous 7,935
363.31%
Holding current value
$527,563
Previous $61,000
395.08%
% of portfolio
0.01%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding TVTX
# of Institutions
184Shares Held
89.8MCall Options Held
137KPut Options Held
181K-
Black Rock Inc. New York, NY7.64MShares$110 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.5MShares$108 Million0.8% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.37MShares$106 Million1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.62MShares$95 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.48MShares$64.3 Million1.14% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $921M
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...